Loading...
Management of acneiform rash associated with anti-EGFR monoclonal antibody treatment
Introduction. Dermatologic adverse events (DAEs) occur in 50-90% of cases during anti-EGFR monoclonal antibody treatment. Positive correlation between the severity of acneiform rash (AR) and the effectiveness of anti-EGFR management is established. Low effectiveness of traditional treatment for AR i...
Na minha lista:
Main Authors: | , , |
---|---|
Format: | Artigo |
Sprog: | Russo |
Udgivet: |
Remedium Group LLC
2020-12-01
|
Serier: | Медицинский совет |
Fag: | |
Online adgang: | https://www.med-sovet.pro/jour/article/view/5951 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|